GSGG — Destiny Alliance Biotechnology Balance Sheet
0.000.00%
FinancialsMicro Cap
Annual balance sheet for Destiny Alliance Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0 | 0 | 0 | 0 | 0 |
| Net Property, Plant And Equipment | — | — | — | — | 0 |
| Total Assets | 0 | 0 | 0 | 0 | 0 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.072 | 0.087 | 0.098 | 0.114 | 0.131 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.072 | 0.087 | 0.098 | 0.114 | 0.131 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.072 | -0.087 | -0.098 | -0.114 | -0.131 |
| Total Liabilities & Shareholders' Equity | 0 | 0 | 0 | 0 | 0 |
| Total Common Shares Outstanding |